These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24895251)

  • 1. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
    Li-Weber M
    Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
    Polier G; Neumann J; Thuaud F; Ribeiro N; Gelhaus C; Schmidt H; Giaisi M; Köhler R; Müller WW; Proksch P; Leippe M; Janssen O; Désaubry L; Krammer PH; Li-Weber M
    Chem Biol; 2012 Sep; 19(9):1093-104. PubMed ID: 22999878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diterpenoid C of Radix Curcumae: an inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway.
    Shen Y; Lu B; Zhang S; Ma ZJ
    Pharm Biol; 2014 Sep; 52(9):1158-65. PubMed ID: 24646305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
    Chang LS; Oblinger JL; Burns SS; Huang J; Anderson LW; Hollingshead MG; Shen R; Pan L; Agarwal G; Ren Y; Roberts RD; O'Keefe BR; Kinghorn AD; Collins JM
    Mol Cancer Ther; 2020 Mar; 19(3):731-741. PubMed ID: 31848295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
    Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
    Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia.
    Song J; Yuan C; Yang J; Liu T; Yao Y; Xiao X; Gajendran B; Xu D; Li YJ; Wang C; Liu W; Wen M; Spaner D; Filmus J; Zacksenhaus E; Zhang Y; Hao X; Ben-David Y
    FEBS J; 2018 Dec; 285(24):4631-4645. PubMed ID: 30387554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from
    Greger H
    Phytochem Rev; 2022; 21(3):725-764. PubMed ID: 34104125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
    Zhu X; Wang K; Zhang K; Zhu L; Zhou F
    Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavaglines as potent anticancer and cytoprotective agents.
    Ribeiro N; Thuaud F; Bernard Y; Gaiddon C; Cresteil T; Hild A; Hirsch EC; Michel PP; Nebigil CG; Désaubry L
    J Med Chem; 2012 Nov; 55(22):10064-73. PubMed ID: 23072299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
    Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
    Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
    Lee EJ; Oh SY; Sung MK
    Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.
    Callahan KP; Minhajuddin M; Corbett C; Lagadinou ED; Rossi RM; Grose V; Balys MM; Pan L; Jacob S; Frontier A; Grever MR; Lucas DM; Kinghorn AD; Liesveld JL; Becker MW; Jordan CT
    Leukemia; 2014 Oct; 28(10):1960-8. PubMed ID: 24577530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tussilago farfara L. augments TRAIL-induced apoptosis through MKK7/JNK activation by inhibition of MKK7‑TIPRL in human hepatocellular carcinoma cells.
    Lee HJ; Cho HS; Jun SY; Lee JJ; Yoon JY; Lee JH; Song HH; Choi SH; Kim SY; Saloura V; Park CG; Kim NS
    Oncol Rep; 2014 Sep; 32(3):1117-23. PubMed ID: 24969837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.
    Basmadjian C; Thuaud F; Ribeiro N; Désaubry L
    Future Med Chem; 2013 Dec; 5(18):2185-97. PubMed ID: 24261894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ERK-MNK-eIF4F signaling pathway mediates TPDHT-induced A549 cell death in vitro and in vivo.
    Guo C; Hou Y; Yu X; Zhang F; Wu X; Wu X; Wang L
    Food Chem Toxicol; 2020 Mar; 137():111158. PubMed ID: 31991197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87.
    Zhang Y; Ren X; Shi M; Jiang Z; Wang H; Su Q; Liu Q; Li G; Jiang G
    Oncol Rep; 2014 Nov; 32(5):2038-46. PubMed ID: 25175884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.